Filter Results:
(5,117)
Show Results For
- All HBS Web
(5,117)
- People (16)
- News (1,939)
- Research (2,530)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Show Results For
- All HBS Web
(5,117)
- People (16)
- News (1,939)
- Research (2,530)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
- 04 Nov 2015
- News
M.B.A.s Get Lessons in Income Inequality
- 03 Aug 2022
- News
How Will Amazon Approach U.S. Primary Care?
- 29 Jul 2021
- News
Medical debt was cut nearly in half in states that expanded Medicaid
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
- May 2014 (Revised March 2017)
- Case
Unilever's Lifebuoy in India: Implementing the Sustainability Plan
Unilever's new Global Brand VP must not only revitalize Lifebuoy soap's sagging market performance, but simultaneously impact the health of one billion people worldwide. The latter challenge comes from Unilever's new CEO who has introduced the Unilever Sustainable... View Details
Keywords: Multinational Management; Corporate Social Responsibility; Strategy Implementation; Marketing Strategy; Mission And Purpose; Change Management; International Business; Global; Fast-moving Consumer Goods; Soap; Corporate Social Responsibility and Impact; Health Care and Treatment; Environmental Sustainability; Global Strategy; Developing Countries and Economies; Beauty and Cosmetics Industry; Health Industry; India
Bartlett, Christopher A. "Unilever's Lifebuoy in India: Implementing the Sustainability Plan." Harvard Business School Case 914-417, May 2014. (Revised March 2017.)
- February 2010 (Revised March 2012)
- Case
U.S. Healthcare Reform: International Perspectives
By: Arthur A. Daemmrich and Elia Cameron
The national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the... View Details
Keywords: Macroeconomics; Insurance; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Laws and Statutes; Business and Government Relations; Health Industry; Health Industry; Germany; United Kingdom; United States
Daemmrich, Arthur A., and Elia Cameron. "U.S. Healthcare Reform: International Perspectives." Harvard Business School Case 710-040, February 2010. (Revised March 2012.)
- 02 Sep 2020
- News
How to Launch a New Biosciences Product: Start Small or Dive in?
- 21 Aug 2023
- News
You’re More Than Your Job: 3 Tips for a Healthier Work-Life Balance
- June 2001 (Revised May 2002)
- Case
Spir-It, Inc. (B): Managing People
When Jack Sindler founded Spir-it, Inc. in 1934, he was the company's sole employee. By 1999, Sindler's firm more than survived its first 55 years. Employment was up to nearly 200, with facilities in two states and work done in three shifts. The product line--which had... View Details
Keywords: Growth Management; Production; Business Growth and Maturation; Interpersonal Communication; Logistics; Human Resources; Diversity Characteristics; Manufacturing Industry
Spear, Steven J. "Spir-It, Inc. (B): Managing People." Harvard Business School Case 601-091, June 2001. (Revised May 2002.)
- 05 Sep 2017
- News
Bargaining With Cancer Patients About Treatment
- 20 Jul 2021
- News
Rewriting the Social Contract
- Web
MS/MBA Biotechnology: Life Sciences | MBA
and life science community include, the Harvard Business School (HBS) Health Care Initiative (HCI), HBS Blavatnik Fellowship in Life Science Entrepreneurship, the Harvard Biotech Club, the HBS View Details
- 29 Jan 2019
- First Look
New Research and Ideas, January 29, 2019
generating consensus on the specifics of benefit-based taxation. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=55548 Harvard Business School Case 818-017 Pricing PatientPing In 2017, Jay Desai, the CEO of Boston-based View Details
Keywords: Dina Gerdeman
- Article
Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology
By: Palak Kundu, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg and Ann Raldow
Background
Psychological safety, a shared belief that interpersonal risk taking is safe, is an important determinant of incident reporting. However, how psychological safety affects near-miss reporting is unclear, as near misses contain contrasting cues that... View Details
Psychological safety, a shared belief that interpersonal risk taking is safe, is an important determinant of incident reporting. However, how psychological safety affects near-miss reporting is unclear, as near misses contain contrasting cues that... View Details
Kundu, Palak, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg, and Ann Raldow. "Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology." Joint Commission Journal on Quality and Patient Safety 47, no. 1 (January 2021): 15–22.
- Research Summary
Fairness and Efficiency in Resource Allocation
In studying the relationship of fairness and efficiency, Professor Trichakis takes the novel approach of looking at varied industries for unifying factors, and he pays special attention to inequities by incorporating both quantitative work in social welfare and the... View Details
- 09 Jan 2015
- News
Report: Don't let integration cause physician micromanagement
- 13 Apr 2017
- News
What Precision Medicine Can Learn from the NFL
- May 2002 (Revised October 2005)
- Case
Marketing Antidepressants: Prozac and Paxil
By: Youngme E. Moon and Kerry Herman
Describes the marketing of Prozac and Paxil, two of the best-selling mental health drugs in history. Set in 2001, several months before the expiration of Prozac's patent, Eli Lilly (Prozac's manufacturer) and GlaxoSmithKline (Paxil's manufacturer) must decide how to... View Details
Keywords: Patents; Product Positioning; Competition; Ethics; Value; Health Care and Treatment; Brands and Branding; Pharmaceutical Industry; United States
Moon, Youngme E., and Kerry Herman. "Marketing Antidepressants: Prozac and Paxil." Harvard Business School Case 502-055, May 2002. (Revised October 2005.)
- October 2022
- Case
Afrigen Biologics: Vaccines for the Global South
By: Debora L. Spar and Julia Comeau
The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details
Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa
Spar, Debora L., and Julia Comeau. "Afrigen Biologics: Vaccines for the Global South." Harvard Business School Case 323-030, October 2022.